The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has ...

This is a prescription medication originally used for diabetes but now approved for weight loss. Most people regained weight ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...

My husband and I have started taking Zepbound for various medical reasons. The medication has significantly and positively impacted the conditions that we hoped it would, but we ...

An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

Data from their most serious competitor, Amgen, suggests the biotech won’t upstage the market leaders.

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.